Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | -0.78% | 26.79 | 14.1% | $157.64m | |
| HZNP | Horizon Therapeutics Plc | -3.54% | 75.74 | 5.6% | $141.54m | |
| ACRS | Aclaris Therapeutics, Inc. | 0.23% | 17.68 | 4.7% | $136.27m | |
| BHC | Bausch Health Cos., Inc. | -0.78% | 26.79 | 0.0% | $108.62m | |
| CTLT | Catalent, Inc. | -1.07% | 114.49 | 2.1% | $105.68m | |
| JAZZ | Jazz Pharmaceuticals Plc | -2.19% | 167.24 | 2.4% | $88.99m | |
| AMRN | Amarin Corp. Plc | -0.62% | 7.51 | 1.5% | $62.52m | |
| UTHR | United Therapeutics Corp. | -1.69% | 166.49 | 14.1% | $60.86m | |
| ISR | IsoRay, Inc. | -5.00% | 2.09 | 2.5% | $57.67m | |
| ACST | Acasti Pharma, Inc. | -2.28% | 0.74 | 0.2% | $55.97m | |
| PRGO | Perrigo Co. Plc | -0.36% | 44.34 | 6.8% | $54.36m | |
| GWPH | GW Pharmaceuticals Plc | 3.18% | 147.95 | 6.1% | $54.26m | |
| SAVA | Cassava Sciences, Inc. | -1.63% | 15.43 | 0.0% | $51.79m | |
| ARGX | argenx SE | -3.06% | 305.68 | 0.0% | $51.73m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.78% | 33.73 | 16.8% | $43.62m |
Company Profile
argenx SE is a clinical-stage biotechnology company, which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include ARGX-113 for the treatment of autoimmune disease myasthenia gravis and ARGX-110 for the treatment of hematological cancer acute myeloid leukemia. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren on April 25, 2008 and is headquartered in Breda, the Netherlands.